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L-2-deoxythreose nucleoside phosphonates are known to 
selectively inhibit HIV
 
without affecting human DNA 
synthesis.
1
 These nucleoside analogues require two 
additional phosphorylation steps by cellular kinases 
before they are incorporated in the viral genome and lead 
to chain termination.  It is believed that a cis orientation of 
the base and the 3’-substituent is a structural requirement 
for optimal conversion to the diphosphate. Inspired by 
these findings, we decided to explore the antiviral 
properties of the threose-based nucleoside analogues, 
which are anticipated to have superior bioavailability 
compared to the parent phosphonates.  
 
The synthesis of analogs involving a Vorbrüggen coupling 
and a Barton-McCombie deoxygenation, will be 
described. 
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